Long intergenic non-protein coding RNA 2135 (LINC02135)

Long intergenic non-protein coding RNA 2135 (LINC02135) is a non-coding RNA gene identified in the human genome with the symbol LINC02135[1][3]. It belongs to the family of long intergenic non-protein coding RNAs (lincRNAs), which are defined as RNAs longer than 200 nucleotides, transcribed autonomously from intergenic regions, and lacking protein-coding capacity[5]. LINC02135 and similar lincRNAs function mainly in the regulation of gene expression, chromatin remodeling, and potential scaffolding of protein complexes. Expression profiles and integrative bioinformatics analyses suggest that LINC02135 is differentially expressed in lung cancer, making it a candidate biomarker for diagnosis. While its precise biological roles remain to be fully elucidated, its inclusion in predictive models for cancer stratification points to importance in disease mechanisms. No known drugs or direct modulators target LINC02135 currently[1][2][3][5].

Other names

LINC02135 (primary)Long intergenic non-protein coding RNA 2135

None established for drugs targeting LINC02135, as direct therapeutic interventions for this specific RNA have not been developed or documented. Theoretical mechanisms for targeting lincRNAs generally include antisense oligonucleotides, siRNA, or CRISPR/Cas systems for modulation of expression[5].